---
title: "China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293676134.md"
description: "China Pharma Holdings, Inc. announced the closing of a $5 million registered direct offering on July 23, 2026. The company sold 2,500,000 shares at $2.00 per share. Net proceeds will be used for working capital and general corporate purposes. FT Global Capital, Inc. served as the exclusive placement agent."
datetime: "2026-07-23T22:52:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293676134.md)
  - [en](https://longbridge.com/en/news/293676134.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293676134.md)
generator: "portal-rs"
---

# China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering

In Haikou, China, on July 23, 2026, China Pharma Holdings, Inc. (NYSE American: CPHI), a specialized pharmaceuticals firm in China, disclosed the completion of its registered direct offering of 2,500,000 shares.

### Related Stocks

- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)

## Related News & Research

- [China Pharma Holdings Announces New Capital Raising Agreement](https://longbridge.com/en/news/293531766.md)
- [China Pharma says unaware of developments behind unusual stock activity](https://longbridge.com/en/news/293380144.md)
- [Can Madrigal Pharmaceuticals (MDGL) Still Offer Value After Its Big Run?](https://longbridge.com/en/news/297367016.md)
- [Is Ligand Pharmaceuticals (LGND) Undervalued On Its Conference Appearance?](https://longbridge.com/en/news/297426603.md)
- [Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors](https://longbridge.com/en/news/297405305.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**